The Journal of General Physiology
Cell MicroControls
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

Published online October 13, 2008
doi:10.1085/jgp.200810030
The Journal of General Physiology, Vol. 132, No. 5, 521-535
The Rockefeller University Press, 0022-1295 $30.00
© 2008 García-Caballero et al.
This Article
Right arrow Full Text
Right arrow Full Text (PDF, 3923K)
Right arrow PPT slides of all figures
Right arrow Alert me when this article is cited
Right arrow Citation Map
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new content in the JGP
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by García-Caballero, A.
Right arrow Articles by Stutts, M. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by García-Caballero, A.
Right arrow Articles by Stutts, M. J.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

ARTICLE

ENaC Proteolytic Regulation by Channel-activating Protease 2



Agustín García-Caballero, Yan Dang, Hong He, and M. Jackson Stutts

Cystic Fibrosis/Pulmonary Research and Treatment Center, University of North Carolina, Chapel Hill, NC 27599

Correspondence to Agustín García-Caballero: acaballe{at}med.unc.edu

Epithelial sodium channels (ENaCs) perform diverse physiological roles by mediating Na+ absorption across epithelial surfaces throughout the body. Excessive Na+ absorption in kidney and colon elevates blood pressure and in the airways disrupts mucociliary clearance. Potential therapies for disorders of Na+ absorption require better understanding of ENaC regulation. Recent work has established partial and selective proteolysis of ENaCs as an important means of channel activation. In particular, channel-activating transmembrane serine proteases (CAPs) and cognate inhibitors may be important in tissue-specific regulation of ENaCs. Although CAP2 (TMPRSS4) requires catalytic activity to activate ENaCs, there is not yet evidence of ENaC fragments produced by this serine protease and/or identification of the site(s) where CAP2 cleaves ENaCs. Here, we report that CAP2 cleaves at multiple sites in all three ENaC subunits, including cleavage at a conserved basic residue located in the vicinity of the degenerin site ({alpha}-K561, β-R503, and {gamma}-R515). Sites in {alpha}-ENaC at K149/R164/K169/R177 and furin-consensus sites in {alpha}-ENaC (R205/R231) and {gamma}-ENaC (R138) are responsible for ENaC fragments observed in oocytes coexpressing CAP2. However, the only one of these demonstrated cleavage events that is relevant for the channel activation by CAP2 takes place in {gamma}-ENaC at position R138, the previously identified furin-consensus cleavage site. Replacement of arginine by alanine or glutamine ({alpha},β,{gamma}R138A/Q) completely abolished both the Na+ current (INa) and a 75-kD {gamma}-ENaC fragment at the cell surface stimulated by CAP2. Replacement of {gamma}-ENaC R138 with a conserved basic residue, lysine, preserved both the CAP2-induced INa and the 75-kD {gamma}-ENaC fragment. These data strongly support a model where CAP2 activates ENaCs by cleaving at R138 in {gamma}-ENaC.


Abbreviations used in this paper: CAP, channel-activating protease; ENaC, epithelial sodium channel; HA-NT, HA–N-terminal; hNE, human neutrophil elastase; MBS, modified Barth's solution; MTSET, [2-(trimethylammonium)ethyl] methanethiosulfonate bromide; PO, open probability; V5-CT, V5–C-terminal; WT, wild-type.

© 2008 García-Caballero et al. This article is distributed under the terms of an Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publication date (see http://www.jgp.org/misc/terms.shtml). After six months it is available under a Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license, as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?




  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents